Aroa Biosurgery Ltd (ASX:ARX) Share Price Update and Market Profile Overview

Anjali Anand

11 August 2026 11:18 PM AEST

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Aroa Biosurgery Ltd (ASX:ARX) shares closed at $0.605 during the latest trading session.
The stock recorded a daily movement of -0.82%, with 49,519 shares traded.
Aroa Biosurgery Ltd recorded a Market Capitalisation of $209.27M.
The company’s shares traded between $0.585 and $0.610 during the session.
The stock recorded a 52-week trading range of $0.450 to $0.770.

Aroa Biosurgery Ltd (ASX:ARX) Share Market Overview

Aroa Biosurgery Ltd (ASX:ARX) is an Australian Securities Exchange-listed company operating within the healthcare sector. The company’s shares were trading at $0.605, with the stock recording a daily movement of -0.82%.

The latest trading activity provides an overview of the company’s market performance, including share price movement, trading volume, market capitalisation and historical trading range. These Market Indicators are commonly used to understand how a Listed security has performed over a particular period.

Share Price Movement and Trading Activity

Aroa Biosurgery Ltd shares traded within a range of $0.585 to $0.610 during the session. The stock closed at $0.605, compared with the previous close of $0.610.

The company recorded trading Volume of 49,519 shares during the session. Trading volume reflects the number of shares exchanged between buyers and sellers and is one of the factors commonly reviewed alongside daily price movements.

The average trading volume for Aroa Biosurgery Ltd was recorded at 49,519 shares, providing additional context on recent market activity.

Market Capitalisation and Share Information

Aroa Biosurgery Ltd recorded a market capitalisation of $209.27M. Market capitalisation represents the total Market Value of a listed company based on its share price and shares outstanding.

The company has 345,900,000 shares on issue, with ordinary fully paid shares listed on the Australian Securities Exchange.

The company’s International Securities Identification Number (ISIN) is AU000000ARX3.

Historical Trading Range

Aroa Biosurgery Ltd shares recorded a 52-week trading range between $0.450 and $0.770.

The 52-week range provides a historical view of the highest and lowest prices recorded by the stock over the previous year. It is commonly used as a reference point when reviewing changes in share price performance over time.

The company’s one-year performance was recorded at -0.82%, reflecting the movement in the share price over the previous 12 months.

Understanding Share Market Performance

Share price movements can change due to multiple factors, including broader market conditions, sector trends, company announcements and investor activity.

For ASX-listed healthcare companies, Market Participants often review trading indicators such as share price changes, trading volume and market capitalisation alongside company disclosures and financial information.

Aroa Biosurgery Ltd’s available market information provides an overview of recent trading activity, while additional company updates and financial reports provide further details about operational performance and Business developments.

Healthcare Sector Market Context

Aroa Biosurgery Ltd is part of the healthcare segment of the Australian share market. Healthcare companies can include businesses involved in medical technologies, products, services and solutions supporting healthcare applications.

The performance of individual healthcare stocks can vary depending on company-specific developments and broader market conditions.

Reviewing market information alongside company disclosures can help provide a broader understanding of listed companies and their position within the Australian Equity market.

Investor Information and Market Tracking

Aroa Biosurgery Ltd (ASX:ARX) provides investors with publicly available market information through its ASX listing. Share price, trading volume, market capitalisation and historical performance are among the key data points commonly monitored for listed companies.

The company’s latest trading information reflects its position in the market at the time of reporting. Future company announcements, financial updates and operational disclosures may provide additional information about business activities.

Conclusion

Aroa Biosurgery Ltd (ASX:ARX) shares closed at $0.605, recording a daily movement of -0.82% with trading volume of 49,519 shares. The company recorded a market capitalisation of $209.27M, with shares trading within a 52-week range of $0.450 to $0.770. This overview highlights key market indicators including share price movement, trading activity and historical performance to provide an educational understanding of ASX-listed company data.

FAQs

Q: What is the ASX ticker code for Aroa Biosurgery Ltd?

A:Aroa Biosurgery Ltd is listed on the Australian Securities Exchange under the ticker code ASX:ARX.

Q: What was Aroa Biosurgery Ltd’s latest share price?

A:Aroa Biosurgery Ltd shares were trading at $0.605.

Q: What was the daily share price movement for ASX:ARX?

A:The stock recorded a daily movement of -0.82%.

Q: What was Aroa Biosurgery Ltd’s market capitalisation?

A:Aroa Biosurgery Ltd recorded a market capitalisation of $209.27M.

Q: Does this article provide investment advice about Aroa Biosurgery Ltd?

A:No. This article is for educational purposes only and does not provide financial advice, valuation, or any recommendation regarding securities.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.